Have drug combinations supplanted stem cell transplantation in myeloma?PALUMBO, Antonio; CAVALLO, Federica.Blood. 2012, Vol 120, Num 24, pp 4692-4698, issn 0006-4971, 7 p.Article

Multiple MyelomaPALUMBO, Antonio; ANDERSON, Kenneth.The New England journal of medicine. 2011, Vol 364, Num 11, pp 1046-1060, issn 0028-4793, 15 p.Article

Management of older patients with multiple myelomaGAY, Francesca; PALUMBO, Antonio.Blood reviews. 2011, Vol 25, Num 2, pp 65-73, issn 0268-960X, 9 p.Article

Optimal management of elderly patients with myelomaCERRATO, Chiara; MINA, Roberto; PALUMBO, Antonio et al.Expert review of anticancer therapy. 2014, Vol 14, Num 2, pp 217-228, issn 1473-7140, 12 p.Article

Shifts in the Therapeutic Paradigm for Patients Newly Diagnosed with Multiple Myeloma: Maintenance Therapy and Overall Survival : Multiple MyelomaPALUMBO, Antonio; ATTAL, Michel; ROUSSEL, Murielle et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1253-1263, issn 1078-0432, 11 p.Article

Management of Newly Diagnosed MyelomaRAJKUMAR, S. Vincent; PALUMBO, Antonio.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, ix-x, 1141-1156Article

Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patientsGUGLIELMELLI, Tommasina; PETRUCCI, Maria Teresa; SAGLIO, Giuseppe et al.British journal of haematology. 2011, Vol 152, Num 1, pp 108-110, issn 0007-1048, 3 p.Article

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple MyelomaPALUMBO, Antonio; HAJEK, Roman; CASCAVILLA, Nicola et al.The New England journal of medicine. 2012, Vol 366, Num 19, pp 1759-1769, issn 0028-4793, 11 p.Article

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myelomaGIACCONE, Luisa; STORER, Barry; BRINGHEN, Sara et al.Blood. 2011, Vol 117, Num 24, pp 6721-6727, issn 0006-4971, 7 p.Article

Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients?PALUMBO, Antonio; MATEOS, Maria-Victoria; BRINGHEN, Sara et al.Blood reviews. 2011, Vol 25, Num 4, pp 181-191, issn 0268-960X, 11 p.Article

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairmentMORABITO, Fortunato; GENTILE, Massimo; PETRUCCI, Maria Teresa et al.Blood. 2011, Vol 118, Num 22, pp 5759-5766, issn 0006-4971, 8 p.Article

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple MyelomaSAN MIGUEL, Jesus F; SCHLAG, Rudolf; DMOSZYNSKA, Anna et al.The New England journal of medicine. 2008, Vol 359, Num 9, pp 906-917, issn 0028-4793, 12 p.Article

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved SurvivalPALUMBO, Antonio; BRINGHEN, Sara; GRASSO, Mariella et al.Journal of clinical oncology. 2014, Vol 32, Num 7, pp 634-640, issn 0732-183X, 7 p.Article

Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical dataOFFIDANI, Massimo; CORVATTA, Laura; CARAFFA, Patrizia et al.Expert review of anticancer therapy. 2014, Vol 14, Num 5, pp 499-510, issn 1473-7140, 12 p.Article

Bortezomib, Melphalan, and Prednisone in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Multicenter, Open Label Phase 1/2 StudyPETRUCCI, Maria Teresa; LEVI, Anna; FOA, Robin et al.Cancer. 2013, Vol 119, Num 5, pp 971-977, issn 0008-543X, 7 p.Article

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized TrialPALUMBO, Antonio; CAVO, Michele; NOZZOLI, Chiara et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 986-993, issn 0732-183X, 8 p.Article

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trialPALUMBO, Antonio; LAROCCA, Alessandra; RUS, Cecilia et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1144-1149, issn 0390-6078, 6 p.Article

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimensKUMAR, Shaji; GIRALT, Sergio; SAN MIGUEL, Jesus et al.Blood. 2009, Vol 114, Num 9, pp 1729-1735, issn 0006-4971, 7 p.Article

Serum Free Light Chain Ratio, Total K/λ Ratio, and Immunofixation Results Are Not Prognostic Factors after Stem Cell Transplantation for Newly Diagnosed Multiple MyelomaGIARIN, Manuela M; GIACCONE, Luisa; SORASIO, Roberto et al.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 8, pp 1510-1516, issn 0009-9147, 7 p.Article

International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell TransplantationPALUMBO, Antonio; VINCENT RAJKUMAR, S; DIMOPOULOS, Meletios A et al.Journal of clinical oncology. 2014, Vol 32, Num 6, pp 587-600, issn 0732-183X, 14 p.Article

Lycopene induce apoptosis in human prostate cells and alters the expression of Bax and Bcl-2 genesDA COSTA PEREIRA SOARES, Nathalia; TEODORO, Anderson Junger; BOROJEVIC, Radovan et al.Lebensmittel - Wissenschaft + Technologie. 2014, Vol 59, Num 2, pp 1290-1297, issn 0023-6438, 8 p., 2Conference Paper

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)PALUMBO, Antonio; BRINGHEN, Sara; ZWEEGMAN, Sonja et al.Blood. 2011, Vol 118, Num 17, pp 4519-4529, issn 0006-4971, 11 p.Article

Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple MyelomaLUDWIG, Heinz; BOLEJACK, Vanessa; SONNEVELD, Pieter et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1599-1605, issn 0732-183X, 7 p.Article

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyCAVO, Michele; TACCHETTI, Paola; OFFIDANI, Massimo et al.Lancet (British edition). 2010, Vol 376, Num 9758, pp 2075-2085, issn 0140-6736, 11 p.Article

Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsBRINGHEN, Sara; LAROCCA, Alessandra; GUGLIELMELLI, Tommasina et al.Blood. 2010, Vol 116, Num 23, pp 4745-4753, issn 0006-4971, 9 p.Article